Efficacy and safety of high doses of safinamide in advanced Parkinson disease.
Rodríguez-Jorge F, Beltrán-Corbellini Á, Chico-García JL, Parra-Díaz P, Baena-Álvarez B, Pagonabarraga J, Pérez-Torre P, Pareés I, López-Sendón JL, Martínez-Castrillo JC, Alonso-Cánovas A.
Rodríguez-Jorge F, et al. Among authors: pagonabarraga j.
Parkinsonism Relat Disord. 2022 Apr;97:73-74. doi: 10.1016/j.parkreldis.2022.03.010. Epub 2022 Mar 23.
Parkinsonism Relat Disord. 2022.
PMID: 35344893
No abstract available.